The Global Helicobacter Pylori Diagnostics Market, valued at approximately USD 601.2 million in 2022, is projected to grow at a robust CAGR of more than 6% during the forecast period from 2023 to 2030 ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

announced today an agreement with Quest Diagnostics (NYSE:DGX), a leading provider of diagnostic information services, to support commercialization of Mainz Biomed’s NextGen screening test for ...

Paradoxical diarrhea happens when loose, watery stool finds a way around hardened, impacted stool in your colon and leaks from your anus. Also called overflow diarrhea, it’s often a symptom of a ...

Patients with inflammatory bowel disease (IBD) reported mostly favorable responses with the use of mail-order kits for stool ...

Mainz Biomed’s stool-based ColoAlert test is designed to detect colorectal ... “We are excited by the opportunity to work with Quest Diagnostics,” commented Guido Baechler, Chief Executive ...

announced today an agreement with Quest Diagnostics (NYSE:DGX), a leading provider of diagnostic information services, to support commercialization of Mainz Biomed’s NextGen screening test for ...

Opens in a new tab or window ORLANDO -- Patients with inflammatory bowel disease (IBD) reported mostly favorable responses with the use of mail-order kits for stool sample collections, according ...